| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alzheimer's disease: clinical trials and drug development
|
Mangialasche, Francesca
|
|
2010
|
9 |
7 |
p. 702-716
15 p.
|
artikel
|
| 2 |
Alzheimer's disease prevention: a reality check
|
The Lancet Neurology,
|
|
2010
|
9 |
7 |
p. 643-
1 p.
|
artikel
|
| 3 |
April, 2010
|
|
|
2010
|
9 |
7 |
p. 659-
1 p.
|
artikel
|
| 4 |
Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study
|
Markus, Hugh S
|
|
2010
|
9 |
7 |
p. 663-671
9 p.
|
artikel
|
| 5 |
Atenolol in uncomplicated hypertension: time for changes
|
Salinas, Alberto Morales
|
|
2010
|
9 |
7 |
p. 652-
1 p.
|
artikel
|
| 6 |
Atenolol in uncomplicated hypertension: time for changes – Author's reply
|
Rothwell, Peter M
|
|
2010
|
9 |
7 |
p. 652-653
2 p.
|
artikel
|
| 7 |
Cerebral microemboli: smoking gun or innocent bystanders?
|
Amarenco, Pierre
|
|
2010
|
9 |
7 |
p. 644-645
2 p.
|
artikel
|
| 8 |
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
|
Pantoni, Leonardo
|
|
2010
|
9 |
7 |
p. 689-701
13 p.
|
artikel
|
| 9 |
Effect modification and ischaemic stroke treatment
|
Hill, Michael D
|
|
2010
|
9 |
7 |
p. 649-651
3 p.
|
artikel
|
| 10 |
Gavin Giovannoni
|
|
|
2010
|
9 |
7 |
p. 659-
1 p.
|
artikel
|
| 11 |
Genomics in our own hands
|
Williams, Ruth
|
|
2010
|
9 |
7 |
p. 656-657
2 p.
|
artikel
|
| 12 |
Gluten sensitivity and the CNS: diagnosis and treatment
|
Hernández-Lahoz, Carlos
|
|
2010
|
9 |
7 |
p. 653-654
2 p.
|
artikel
|
| 13 |
Gluten sensitivity and the CNS: diagnosis and treatment
|
Versino, Maurizio
|
|
2010
|
9 |
7 |
p. 653-
1 p.
|
artikel
|
| 14 |
Gluten sensitivity and the CNS: diagnosis and treatment – Authors' reply
|
Hadjivassiliou, Marios
|
|
2010
|
9 |
7 |
p. 654-655
2 p.
|
artikel
|
| 15 |
Improving combination trials for multiple sclerosis
|
Trojano, Maria
|
|
2010
|
9 |
7 |
p. 646-647
2 p.
|
artikel
|
| 16 |
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
|
Kapoor, Raju
|
|
2010
|
9 |
7 |
p. 681-688
8 p.
|
artikel
|
| 17 |
Memories of a neurosurgeon
|
Kitchen, Neil
|
|
2010
|
9 |
7 |
p. 660-661
2 p.
|
artikel
|
| 18 |
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial
|
Ravnborg, Mads
|
|
2010
|
9 |
7 |
p. 672-680
9 p.
|
artikel
|
| 19 |
Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers
|
Jansen, Michael
|
|
2010
|
9 |
7 |
p. 717-726
10 p.
|
artikel
|
| 20 |
Multiple sclerosis: risk factors, prodromes, and potential causal pathways
|
Ramagopalan, Sreeram V
|
|
2010
|
9 |
7 |
p. 727-739
13 p.
|
artikel
|
| 21 |
Neurocritical care: an emerging discipline
|
Kramer, Andreas
|
|
2010
|
9 |
7 |
p. 661-
1 p.
|
artikel
|
| 22 |
News in brief
|
|
|
2010
|
9 |
7 |
p. 662-
1 p.
|
artikel
|
| 23 |
Ralph Sacco: putting the heart into neurology
|
Burton, Adrian
|
|
2010
|
9 |
7 |
p. 658-
1 p.
|
artikel
|
| 24 |
Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis
|
Polman, Chris H
|
|
2010
|
9 |
7 |
p. 740-750
11 p.
|
artikel
|
| 25 |
Stroke—a call for papers
|
Frankish, Helen
|
|
2010
|
9 |
7 |
p. 651-
1 p.
|
artikel
|
| 26 |
Where next for stroke?
|
Spratt, Neil
|
|
2010
|
9 |
7 |
p. 660-
1 p.
|
artikel
|
| 27 |
Where to go next with neuroprotection in multiple sclerosis?
|
Fazekas, Franz
|
|
2010
|
9 |
7 |
p. 647-648
2 p.
|
artikel
|
Tijdschrift beschrijving